Explore Global Companies & Account Intelligence

Aqueti builds camera array imaging systems of extreme resolution for interactive imaging applications. With significant expertise in optical design, computational imaging, computer architectures, and realtime processing we are developing next-generation imaging systems for applications ranging from drones to security to broadcast.

Aquí Madrid es un medio de comunicación digital e independiente, centrado en temas relativos a la Comunidad de Madrid, pero también con la mirada puesta en todo lo que ocurre en España y en el mundo. Nace con el único objetivo de ofrecer un periodismo de todos.

We customize and design water treatment systems for both city and well water sources for residential, commercial, and industrial applications. We greatly care about our customer's concerns for their water quality and wish to offer only the best water treatment solutions for their needs.

Aquient drives transformational change with our clients through better use of data and technology. We look for ways to help our clients adopt new strategic direction, technology and operational improvement to remain nimble and able to capture opportunities as they arise. Our focus is data management, innovation, marketing strategy and execution, data science & analytics and artificial intelligence. We primarily work with Salesforce and Google technologies and platforms. aquient brings a consultative approach to both strategy and implementation in these areas We only hire the best, but we hire a diverse range of skillsets, thinking and experience to ensure a holistic approach to modern business problems is applied to our work.

Independent Film Production Company / Film and photography Cyclorama Studio

Freedom comes through knowledge, we believe that advancement of knowledge, innovation and collaboration will bring about change for good. Imagine a world where barriers and hindrances to economic freedom is overcome, where every entity and individual can transact freely and understand clearly the true risks and opportunities in global markets. That's our commitment at Aquifer Institute.

AQUIKO has been developed by Aquatic Control Engineering Ltd (ACE). ACE has over 25 years of experience in the supply and installation of specialist equipment to the water industry. ACE originally pioneered Dutch HDPE and Stainless-steel manufactured water flow control equipment in the UK. Over the years ACE’s reputation and expertise has grown to them being the UK Market leader in water flow control products. It is this expertise that has driven the development of the AQUIKO product range, tailoring the new designs to suit the UK market. Years of ACE supplying and installing these products in the UK mean’s that we could always see lots of possible improvements for the HDPE and stainless-steel product AQUIKO has provided us the opportunity to embed these improvements into the product. The AQUIKO product range has been designed and manufactured in the UK using the most cutting-edge techniques. All of our products are made to highest exacting standards and have a design life of 50 years*. AQUIKO is backed up by a team of experts on hand to deliver specialist advice and guidance on your product needs. We stock products from 100mm to 1200mm the majority of which is available for same-day dispatch from our UK warehouse.

Die Aquila Gruppe ist ein Verbund unabhängiger Vermögensverwaltungsgesellschaften und Family Offices in der Schweiz mit über 100 Mitarbeitern und Partnern. Als Vermögensverwalterin für internationale private und institutionelle Investoren ist die Gruppe kontinuierlich gewachsen und verwaltet heute Kundengelder von über CHF 5,3 Milliarden. Das im Jahr 2000 gegründete Stammhaus, die Aquila & Co. AG, mit Sitz in Zürich, betreut darüber hinaus taktische Beratungsmandate von institutionellen Kunden von über CHF 6,5 Milliarden und verwaltet in der Schweiz und dem Fürstentum Lichtenstein zugelassene Fonds mit einem Volumen von CHF 350 Mio. Die Aquila & Co. AG hat den Status einer Bank und untersteht der Aufsicht der Eidgenössischen Finanzmarktaufsicht (FINMA). Mit der Bankenlizenz verfügt die Aquila & Co. AG über die Möglichkeit, europaweit kollektive Kapitalanlagen (z.B. Investmentfonds) zu verwalten oder zu beraten. Zudem ist das Stammhaus seit April 2010 von der BaFin berechtigt grenzüberschreitend in Deutschland für institutionelle Investoren tätig zu sein. Unsere Kernkompetenzen für institutionelle Investoren auf einen Blick: • Investment Management • Anlageberatung • Consulting Wir arbeiten völlig unabhängig von Produktanbietern und können so unsere Dienstleistungen frei von jeglichen Interessenskonflikten erbringen.

AQUILA Aviation ist ein mittelständisches Unternehmen im brandenburgischen Schönhagen, südlich von Berlin. Wir sind Hersteller des innovativen, einmotorigen, komplett in Handarbeit gefertigten VLA-Flugzeuges, der AQUILA A211. Wir bieten Handarbeit auf hohem Niveau und sind stolz auf das Prädikat "Made in Germany". Darüber hinaus sind wir ihr kompetenter Ansprechpartner in den Bereichen FVK & Leichtbau, Fleugzeugwartung und Instandhaltung sowie CAMO (bis 2to MTOW).

Aquila Basilea is an independent Wealth Management company that works under the professional wings of www.aquila.ch

In 2021, aquila biolabs was acquired by Scientific Bioprocessing, Inc. For all further information, please visit www.scientificbio.com

Aquila BioMedical is an innovative preclinical contract research organization that offers clients renowned research expertise across a range of therapeutic areas with a focus on Immuno-Oncology, Immunology and Multiplex Histology. Bespoke services combine advanced academic models with protocolled techniques, delivered from within dedicated laboratories, to provide high-value data, defining both efficacy and the mechanism of action of drug candidate compounds. A key feature of the Aquila offering is the partnering of services with world-leading academics to provide expert advice and interpretation of the data. Aquila has developed novel technologies to help you better understand the cellular and molecular events that occur with compound administration. Our assays allow both Phenotypic Screening and target based research methods to enable hit identification and optimisation of compound and target selection, directly increasing the compound success rate and reducing the overall cost associated with drug development.